Five things to know:
1. Amwell raised almost $200 million in May as the need for telehealth drastically increased during the pandemic. The company reported a 1,000 percent increase in virtual visits due to COVID-19, with that reaching 3,000 to 4,000 percent growth in some areas.
2. The company hired Goldman Sachs and Morgan Stanley to lead the deal.
3. The IPO could take place in September, according to the report.
4. Current Amwell investors include Anthem, Takeda and Jefferson Health in Philadelphia. The company launched a telehealth service platform designed for smaller physician practices in April.
5. Amwell is not commenting on the IPO at this time.
More articles on telehealth:
Anthem Blue Cross of California uses telehealth to expand access: 4 details
UCLA report: Telehealth must address broadband, infrastructure issues for vulnerable populations
Bill would require government to study impact of telehealth during pandemic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
